CGHS Issues Guidelines for Prescription of Injectable GLP-1 Drugs for Obesity and Type-2 Diabetes The Ministry of Health & Family Welfare has issued comprehensive guidelines regulating the prescription of Injectable GLP-1 Receptor Agonists under the Central Government Health Scheme (CGHS) and the Central Services (Medical Attendance) Rules, 1944
It does not cover all possible uses, actions, precautions, side effects, or interactions of the medications shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular medication
Glucagon-like peptide-1 of brainstem origin activates dorsomedial hypothalamic neurons in satiated rats
10.1016/j.bbrc.2011.11.047 Biochem Biophys Res Commun
Typically, it is used until the target weight is achieved
Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushings syndrome